119 related articles for article (PubMed ID: 12782409)
1. Expression of adenylyl cyclase types III and VI in human hyperfunctioning thyroid nodules.
Celano M; Arturi F; Presta I; Bruno R; Scarpelli D; Calvagno MG; Cristofaro C; Bulotta S; Giannasio P; Sacco R; Filetti S; Russo D
Mol Cell Endocrinol; 2003 May; 203(1-2):129-35. PubMed ID: 12782409
[TBL] [Abstract][Full Text] [Related]
2. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
Holzapfel HP; Bergner B; Wonerow P; Paschke R
Eur J Endocrinol; 2002 Jul; 147(1):109-16. PubMed ID: 12088927
[TBL] [Abstract][Full Text] [Related]
3. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
[TBL] [Abstract][Full Text] [Related]
5. Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas.
Peri A; Luciani P; Tonacchera M; Agretti P; Baglioni-Peri S; Buci L; Conforti B; Cioppi F; Biliotti G; Serio M; Vitti P; Chiovato L
Eur J Endocrinol; 2002 Jun; 146(6):759-66. PubMed ID: 12039695
[TBL] [Abstract][Full Text] [Related]
6. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
[TBL] [Abstract][Full Text] [Related]
7. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter.
Tonacchera M; Vitti P; Agretti P; Giulianetti B; Mazzi B; Cavaliere R; Ceccarini G; Fiore E; Viacava P; Naccarato A; Pinchera A; Chiovato L
Thyroid; 1998 Jul; 8(7):559-64. PubMed ID: 9709907
[TBL] [Abstract][Full Text] [Related]
8. Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure.
Espinasse I; Iourgenko V; Richer C; Heimburger M; Defer N; Bourin MC; Samson F; Pussard E; Giudicelli JF; Michel JB; Hanoune J; Mercadier JJ
Cardiovasc Res; 1999 Apr; 42(1):87-98. PubMed ID: 10434999
[TBL] [Abstract][Full Text] [Related]
9. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas.
Persani L; Lania A; Alberti L; Romoli R; Mantovani G; Filetti S; Spada A; Conti M
J Clin Endocrinol Metab; 2000 Aug; 85(8):2872-8. PubMed ID: 10946896
[TBL] [Abstract][Full Text] [Related]
10. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
Parma J; Duprez L; Van Sande J; Hermans J; Rocmans P; Van Vliet G; Costagliola S; Rodien P; Dumont JE; Vassart G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2695-701. PubMed ID: 9253356
[TBL] [Abstract][Full Text] [Related]
11. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
[TBL] [Abstract][Full Text] [Related]
12. Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules.
Gozu H; Avsar M; Bircan R; Claus M; Sahin S; Sezgin O; Deyneli O; Paschke R; Cirakoglu B; Akalin S
Thyroid; 2005 Apr; 15(4):389-97. PubMed ID: 15876166
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the thyrotropin receptor signal transduction pathway in the hyperfunctioning thyroid nodules from multinodular goiters: a study in the Turkish population.
Gozu H; Avsar M; Bircan R; Sahin S; Deyneli O; Cirakoglu B; Akalin S
Endocr J; 2005 Oct; 52(5):577-85. PubMed ID: 16284436
[TBL] [Abstract][Full Text] [Related]
14. A dominant negative Galphas mutant that prevents thyroid-stimulating hormone receptor activation of cAMP production and inositol 1,4,5-trisphosphate turnover: competition by different G proteins for activation by a common receptor.
Cleator JH; Ravenell R; Kurtz DT; Hildebrandt JD
J Biol Chem; 2004 Aug; 279(35):36601-7. PubMed ID: 15234971
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features.
Arturi F; Capula C; Chiefari E; Filetti S; Russo D
Exp Clin Endocrinol Diabetes; 1998; 106(3):234-6. PubMed ID: 9710366
[TBL] [Abstract][Full Text] [Related]
16. Expression of type V adenylyl cyclase is required for epidermal growth factor-mediated stimulation of cAMP accumulation.
Chen Z; Nield HS; Sun H; Barbier A; Patel TB
J Biol Chem; 1995 Nov; 270(46):27525-30. PubMed ID: 7499211
[TBL] [Abstract][Full Text] [Related]
17. The 3',5'-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas.
Brunetti A; Chiefari E; Filetti S; Russo D
Endocrinology; 2000 Feb; 141(2):722-30. PubMed ID: 10650954
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort.
Sancak S; Jaeschke H; Eren F; Tarcin O; Guellueoglu B; Sen LS; Sever Z; Gozu HI; Bircan R; Akalin S; Paschke R; Eszlinger M
Horm Metab Res; 2011 Jul; 43(8):562-8. PubMed ID: 21773967
[TBL] [Abstract][Full Text] [Related]
19. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.
Ammer H; Christ TE
J Neurochem; 2002 Nov; 83(4):818-27. PubMed ID: 12421353
[TBL] [Abstract][Full Text] [Related]
20. Effect of hypothyroidism on adenylyl cyclase activity and subtype gene expression in brown adipose tissue.
Chaudhry A; Granneman JG
Am J Physiol; 1997 Aug; 273(2 Pt 2):R762-7. PubMed ID: 9277566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
